Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Payables (2023 - 2025)

Camp4 Therapeutics' Payables history spans 3 years, with the latest figure at $182000.0 for Q4 2025.

  • For Q4 2025, Payables fell 84.96% year-over-year to $182000.0; the TTM value through Dec 2025 reached $182000.0, down 84.96%, while the annual FY2025 figure was $182000.0, 84.96% down from the prior year.
  • Payables for Q4 2025 was $182000.0 at Camp4 Therapeutics, down from $585000.0 in the prior quarter.
  • Across five years, Payables topped out at $3.9 million in Q3 2024 and bottomed at $182000.0 in Q4 2025.
  • The 3-year median for Payables is $1.2 million (2025), against an average of $1.4 million.
  • The largest annual shift saw Payables increased 16.12% in 2024 before it plummeted 84.96% in 2025.
  • A 3-year view of Payables shows it stood at $1.0 million in 2023, then grew by 16.12% to $1.2 million in 2024, then tumbled by 84.96% to $182000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Payables are $182000.0 (Q4 2025), $585000.0 (Q3 2025), and $1.2 million (Q2 2025).